SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Arcolab gets USFDA approval for Acarbose Tablets

28 Jul 2011 Evaluate

Strides Arcolab has received United States Food and Drug Administration (USFDA) approval for Acarbose Tablets, 25mg, 50mg and 100mg. Acarbose is a niche anti-diabetic drug used to treat type 2 diabetes mellitus. According to March 2011 IMS data, total US market for Acarbose Tablets approximated to $21 million with no Indian generic players in the market.

The Pharma division has a total of 37 filings with USFDA out of which 21 under the PEPFAR programme and 16 as Generics. Approvals to date are 22, 17 under PEPFAR and 5 Generics. This product will be marketed and sold by Perrigo under a profit share partnership. Product is expected to be launched shortly within Q3’ 2011.

Recently, Onco Therapies, a division of Agila, which is a wholly owned subsidiary of Strides Arcolab, had received United States Food and Drug Administration (US FDA) approval for Gemcitabine for Injection USP in 200mg, 1 gm and 2 gm dosage forms.

Strides Pharma Scien Share Price

1002.65 1.95 (0.19%)
20-Apr-2026 14:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.90
Dr. Reddys Lab 1234.40
Cipla 1232.35
Zydus Lifesciences 936.50
Lupin 2328.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×